{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T00:08:17Z","timestamp":1795133297773,"version":"4.10.3"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Stereotactic body radiation therapy (SBRT) represents an effective therapeutic strategy for early-stage non\u2013small cell lung cancer (NSCLC); however, local and systemic recurrences represent ongoing challenges. Computed tomography (CT) radiomics-based risk models can potentially be used to predict the risk of local recurrence on pretreatment CT scans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Development of a radiomics model to predict local recurrence after SBRT in patients with NSCLC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-institution study includes a retrospective case-control training set (20 patients with local recurrence and 40 control subjects) and an independent validation set (198 consecutive cases) of patients with early-stage NSCLC treated with SBRT. Tumors were semiautomatically segmented, and 102 quantitative radiomic features, including texture, landscape, spatial, nodule shape, and nodule surface features, were extracted. These features were included in three separate multivariable models to predict the risk of recurrence on the basis of pre-SBRT, post-SBRT, and the difference between the pre-SBRT and post-SBRT scans (Delta model). The pre-SBRT model was subsequently validated in an independent validation set.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirteen independent variables were selected for the models using the Boruta algorithm. The sensitivity, specificity, and area under the curve of the pre-SBRT, post-SBRT, and Delta models were 85%, 90%, and 0.91; 85%, 92.5%, and 0.92; and 85%, 92.5%, and 0.94, respectively. The pre-SBRT model was validated in the independent validation set (area under the curve, 0.89; confidence interval, 0.83\u20130.92), because this model was believed to be the most useful to assist in individualized treatment planning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Radiomic analysis facilitated the development of three high-performing models predicting local recurrence using either pre-SBRT CT, post-SBRT CT, or the change between these two. We successfully validated the most clinically relevant model, the pre-SBRT model. Although this model needs further validation, it may facilitate individualized surveillance, treatment planning, and selection of adjuvant therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202410-1047oc","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T11:37:51Z","timestamp":1744285071000},"page":"1236-1243","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":4,"title":["Radiomics-Based Prediction of Local Recurrence after Stereotactic Body Radiation Therapy for Early-Stage Non\u2013Small Cell Lung Cancer"],"prefix":"10.1093","volume":"22","author":[{"given":"Chioma P.","family":"Ogbonna","sequence":"first","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Breen","sequence":"additional","affiliation":[{"name":"Department of Radiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Le Noach","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine"},{"name":"Brest University Hospital, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasan","family":"Rajagopalan","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biomedical Engineering"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan J.","family":"Hostetter","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Maldonado","sequence":"additional","affiliation":[{"name":"Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Bartholmai","sequence":"additional","affiliation":[{"name":"Department of Radiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Merrell","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Peikert","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"2026012203125011100_bib1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1200\/JCO.2017.74.9671","article-title":"Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: American Society of Clinical Oncology endorsement of the American Society for Radiation Oncology evidence-based guideline","volume":"36","author":"Schneider","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026012203125011100_bib2","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/JTO.0b013e318219aac5","article-title":"Radiological changes after stereotactic radiotherapy for stage I lung cancer","volume":"6","author":"Dahele","year":"2011","journal-title":"J Thorac Oncol"},{"key":"2026012203125011100_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.radonc.2007.10.044","article-title":"Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study","volume":"85","author":"Guckenberger","year":"2007","journal-title":"Radiother Oncol"},{"key":"2026012203125011100_bib4","doi-asserted-by":"crossref","first-page":"W678","DOI":"10.2214\/AJR.10.4659","article-title":"Complications of CT-guided percutaneous needle biopsy of the chest: prevention and management","volume":"196","author":"Wu","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"2026012203125011100_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"2026012203125011100_bib6","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1002\/mp.12309","article-title":"Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy","volume":"44","author":"Li","year":"2017","journal-title":"Med Phys"},{"key":"2026012203125011100_bib7","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ijrobp.2015.12.369","article-title":"Detection of local cancer recurrence after stereotactic ablative radiation therapy for lung cancer: physician performance versus radiomic assessment","volume":"94","author":"Mattonen","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026012203125011100_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.semtcvs.2015.12.015","article-title":"Computer-aided nodule assessment and risk yield risk management of adenocarcinoma: the future of imaging?","volume":"28","author":"Foley","year":"2016","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"2026012203125011100_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2021.03.001","article-title":"Ablative radiotherapy for ultracentral lung cancers: dosimetric, geometric, and volumetric predictors of outcomes and toxicity","volume":"158","author":"Breen","year":"2021","journal-title":"Radiother Oncol"},{"key":"2026012203125011100_bib10","first-page":"225","article-title":"Lung stereotactic body radiotherapy using a coplanar versus a non-coplanar beam technique: a comparison of clinical outcomes","volume":"2","author":"Hallemeier","year":"2013","journal-title":"J Radiosurg SBRT"},{"key":"2026012203125011100_bib11","doi-asserted-by":"crossref","first-page":"2002485","DOI":"10.1183\/13993003.02485-2020","article-title":"Validation of the BRODERS classifier (Benign versus aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules","volume":"57","author":"Maldonado","year":"2021","journal-title":"Eur Respir J"},{"key":"2026012203125011100_bib12","first-page":"e73082","article-title":"Radiomics as biomarkers for the treatment of non-small cell lung cancer with stereotactic body radiation therapy: a review of concepts","volume":"16","author":"Ramasamy","year":"2024","journal-title":"Cureus"},{"key":"2026012203125011100_bib13","doi-asserted-by":"crossref","first-page":"e0196910","DOI":"10.1371\/journal.pone.0196910","article-title":"Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial","volume":"13","author":"Peikert","year":"2018","journal-title":"PLoS One"},{"key":"2026012203125011100_bib14","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jtho.2019.04.022","article-title":"Computed tomography-based score indicative of lung cancer aggression (SILA) predicts the degree of histologic tissue invasion and patient survival in lung adenocarcinoma spectrum","volume":"14","author":"Varghese","year":"2019","journal-title":"J Thorac Oncol"},{"key":"2026012203125011100_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i11","article-title":"Feature selection with the Boruta package","volume":"36","author":"Kursa","year":"2010","journal-title":"J Stat Softw"},{"key":"2026012203125011100_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/JTO.0b013e3182843721","article-title":"Noninvasive characterization of the histopathologic features of pulmonary nodules of the lung adenocarcinoma spectrum using computer-aided nodule assessment and risk yield (CANARY) \u2013 a pilot study","volume":"8","author":"Maldonado","year":"2013","journal-title":"J Thorac Oncol"},{"key":"2026012203125011100_bib17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1164\/rccm.201503-0443OC","article-title":"Noninvasive computed tomography-based risk stratification of lung adenocarcinomas in the National Lung Screening Trial","volume":"192","author":"Maldonado","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203125011100_bib18","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/JTO.0000000000000319","article-title":"Noninvasive risk stratification of lung adenocarcinoma using quantitative computed tomography","volume":"9","author":"Raghunath","year":"2014","journal-title":"J Thorac Oncol"},{"key":"2026012203125011100_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1183\/09031936.00071812","article-title":"Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis","volume":"43","author":"Maldonado","year":"2014","journal-title":"Eur Respir J"},{"key":"2026012203125011100_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijrobp.2021.11.027","article-title":"A systematic review into the radiologic features predicting local recurrence after stereotactic ablative body radiotherapy (SABR) in patients with non-small cell lung cancer (NSCLC)","volume":"113","author":"Lee","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026012203125011100_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.radonc.2013.06.047","article-title":"High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer","volume":"109","author":"Huang","year":"2013","journal-title":"Radiother Oncol"},{"key":"2026012203125011100_bib22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/1754-9485.12599","article-title":"Prognostic significance of SUVmax on pretreatment 18F-FDG PET\/CT in early-stage non-small cell lung cancer treated with stereotactic body radiotherapy: a meta-analysis","volume":"61","author":"Dong","year":"2017","journal-title":"J Med Imaging Radiat Oncol"},{"key":"2026012203125011100_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13014-018-0980-7","article-title":"Response criteria in solid tumors (PERCIST\/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy","volume":"13","author":"Pierson","year":"2018","journal-title":"Radiat Oncol"},{"key":"2026012203125011100_bib24","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2967\/jnumed.119.228106","article-title":"Pretreatment 18F-FDG PET\/CT radiomics predict local recurrence in patients treated with stereotactic body radiotherapy for early-stage non-small cell lung cancer: a multicentric study","volume":"61","author":"Dissaux","year":"2020","journal-title":"J Nucl Med"},{"key":"2026012203125011100_bib25","doi-asserted-by":"crossref","first-page":"17620","DOI":"10.1038\/s41598-017-17659-6","article-title":"Computer-aided nodule assessment and risk yield (CANARY) may facilitate non-invasive prediction of EGFR mutation status in lung adenocarcinomas","volume":"7","author":"Clay","year":"2017","journal-title":"Sci Rep"},{"key":"2026012203125011100_bib26","doi-asserted-by":"crossref","first-page":"e0198118","DOI":"10.1371\/journal.pone.0198118","article-title":"Assessing the inter-observer variability of computer-aided nodule assessment and risk yield (CANARY) to characterize lung adenocarcinomas","volume":"13","author":"Nakajima","year":"2018","journal-title":"PLoS One"},{"key":"2026012203125011100_bib27","doi-asserted-by":"crossref","first-page":"041010","DOI":"10.1117\/1.JMI.2.4.041010","article-title":"Imaging texture analysis for automated prediction of lung cancer recurrence after stereotactic radiotherapy","volume":"2","author":"Mattonen","year":"2015","journal-title":"J Med Imaging (Bellingham)"},{"key":"2026012203125011100_bib28","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/RCT.0000000000000262","article-title":"Computed tomography assessment of ablation zone enhancement in patients with early-stage lung cancer after stereotactic ablative radiotherapy","volume":"39","author":"Moore","year":"2015","journal-title":"J Comput Assist Tomogr"},{"key":"2026012203125011100_bib29","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S1470-2045(21)00347-8","article-title":"Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis","volume":"22","author":"Scott","year":"2021","journal-title":"Lancet Oncol"},{"key":"2026012203125011100_bib30","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Aup\u00e9rin","year":"2010","journal-title":"J Clin Oncol"},{"key":"2026012203125011100_bib31","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jnci\/djr325","article-title":"Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410","volume":"103","author":"Curran","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"2026012203125011100_bib32","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(23)01384-3","article-title":"Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial","volume":"402","author":"Chang","year":"2023","journal-title":"Lancet"},{"key":"2026012203125011100_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40425-017-0300-z","article-title":"Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group","volume":"5","author":"Puzanov","year":"2017","journal-title":"J Immunother Cancer"},{"key":"2026012203125011100_bib34","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1158\/2159-8290.CD-17-0716","article-title":"Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling","volume":"7","author":"Chaudhuri","year":"2017","journal-title":"Cancer Discov"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/22\/8\/1236\/66007596\/annalsats_22_8_1236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/22\/8\/1236\/66007596\/annalsats_22_8_1236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:13:43Z","timestamp":1769069623000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/22\/8\/1236\/8380507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,1]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202410-1047oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"2024-10-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}